Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8712)
All Articles published online
|
Dec 14, 2012 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Smith LA, Gaya DR. Utility of faecal calprotectin analysis in adult inflammatory bowel disease. World J Gastroenterol 2012; 18(46): 6782-6789 [PMID: 23239916 DOI: 10.3748/wjg.v18.i46.6782] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i46/6782.htm |
| Number | Citing Articles |
| 1 |
Kristine Holgersen, Burak Kutlu, Brian Fox, Kyle Serikawa, James Lord, Axel Kornerup Hansen, Thomas Lindebo Holm. High-Resolution Gene Expression Profiling Using RNA Sequencing in Patients With Inflammatory Bowel Disease and in Mouse Models of Colitis. Journal of Crohn's and Colitis 2015; 9(6): 492 doi: 10.1093/ecco-jcc/jjv050
|
| 2 |
Tim Hodgson, Barbara Carey, Emma Hayes, Richeal Ni Riordain, Priya Thakrar, Sarah Viggor, Paula Farthing. Contemporary Oral Medicine. 2018; : 1 doi: 10.1007/978-3-319-28100-1_4-1
|
| 3 |
Yi Fengming, Wu Jianbing. Biomarkers of Inflammatory Bowel Disease. Disease Markers 2014; 2014: 1 doi: 10.1155/2014/710915
|
| 4 |
Tim Hodgson, Barbara Carey, Emma Hayes, Richeal Ni Riordain, Priya Thakrar, Sarah Viggor, Paula Farthing. Contemporary Oral Medicine. 2019; : 255 doi: 10.1007/978-3-319-72303-7_4
|
| 5 |
A Swaminathan, G M Borichevsky, C M Frampton, A S Day, M B Hampton, A J Kettle, R B Gearry. Comparison of Fecal Calprotectin and Myeloperoxidase in Predicting Outcomes in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2024; doi: 10.1093/ibd/izae032
|
| 6 |
Stephan R Vavricka, Henriette Heinrich, Simon Buetikofer, Flavia Breitenmoser, Emanuel Burri, Xiaoye Schneider-Yin, Jasmin Barman-Aksoezen, Luc Biedermann, Michael Scharl, Jonas Zeitz, Gerhard Rogler, Benjamin Misselwitz, Matthias Sauter. The Vampire Study: Significant elevation of faecal calprotectin in healthy volunteers after 300 ml blood ingestion mimicking upper gastrointestinal bleeding. United European Gastroenterology Journal 2018; 6(7): 1007 doi: 10.1177/2050640618774416
|
| 7 |
Alicia Garcia-Anguita, Artemisia Kakourou, Konstantinos K. Tsilidis. Biomarkers of Inflammation and Immune Function and Risk of Colorectal Cancer. Current Colorectal Cancer Reports 2015; 11(5): 250 doi: 10.1007/s11888-015-0282-5
|
| 8 |
Erika Lehtola, Johanna Haapamäki, Martti A. Färkkilä. Outcome of inflammatory bowel disease patients treated with TNF-α inhibitors: two-year follow-up. Scandinavian Journal of Gastroenterology 2016; 51(12): 1476 doi: 10.1080/00365521.2016.1218539
|
| 9 |
Greg Rosenfeld, Astrid-Jane Greenup, Andrew Round, Oliver Takach, Lawrence Halparin, Abid Saadeddin, Jin Kee Ho, Terry Lee, Robert Enns, Brian Bressler. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease. World Journal of Gastroenterology 2016; 22(36): 8211-8218 doi: 10.3748/wjg.v22.i36.8211
|
| 10 |
Mehrnaz Nouri, Björn Weström, Shahram Lavasani. Elevated Fecal Calprotectin Accompanied by Intestinal Neutrophil Infiltration and Goblet Cell Hyperplasia in a Murine Model of Multiple Sclerosis. International Journal of Molecular Sciences 2023; 24(20): 15367 doi: 10.3390/ijms242015367
|
| 11 |
Maria Elena Lozoya Angulo, Ignacio de las Heras Gómez, Miriam Martinez Villanueva, Jose Antonio Noguera Velasco, Francisco Avilés Plaza. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders. Gastroenterología y Hepatología (English Edition) 2017; 40(3): 125 doi: 10.1016/j.gastre.2017.02.002
|
| 12 |
Nages Nagaratnam, Kujan Nagaratnam, Gary Cheuk. Geriatric Diseases. 2018; : 153 doi: 10.1007/978-3-319-33434-9_16
|
| 13 |
Estefanía Moreno-Rincón, José Manuel Benítez, Francisco Javier Serrano-Ruiz, Juan María Vázquez-Morón, Héctor Pallarés-Manrique, José Manuel Herrera-Justiniano, Eduardo Leo-Carnerero, María Rosario Gómez-García, María José Cabello-Tapia, Manuel Castro-Fernández, María Rojas-Feria, Luisa Castro-Laria, Federico Argüelles-Arias, Raquel Camargo-Camero, Guillermo Alcaín-Martínez, Eva Iglesias-Flores, Valle García-Sánchez. Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal. Inflammatory Bowel Diseases 2015; 21(7): 1564 doi: 10.1097/MIB.0000000000000400
|
| 14 |
Maria Elena Lozoya Angulo, Ignacio de las Heras Gómez, Miriam Martinez Villanueva, Jose Antonio Noguera Velasco, Francisco Avilés Plaza. Calprotectina fecal, marcador eficaz en la diferenciación de enfermedades inflamatorias intestinales y trastornos funcionales gastrointestinales. Gastroenterología y Hepatología 2017; 40(3): 125 doi: 10.1016/j.gastrohep.2016.04.009
|
| 15 |
Nages Nagaratnam, Kujan Nagaratnam, Gary Cheuk. Geriatric Diseases. 2017; : 1 doi: 10.1007/978-3-319-32700-6_16-1
|
| 16 |
Juan Ricardo Márquez Velásquez. Enfermedad de Crohn. Enfoque diagnóstico y terapéutico de las primeras visitas . Revista Colombiana de Gastroenterología 2014; 29(4): 404 doi: 10.22516/25007440.438
|
| 17 |
A O'Meara, N Kapel, A Xhaard, F Sicre de Fontbrune, D Manéné, N Dhedin, R P de Latour, G Socié, M Robin. Fecal calprotectin and α1-antitrypsin dynamics in gastrointestinal GvHD. Bone Marrow Transplantation 2015; 50(8): 1105 doi: 10.1038/bmt.2015.109
|
| 18 |
Shannon Chang, Lisa Malter, David Hudesman. Disease monitoring in inflammatory bowel disease. World Journal of Gastroenterology 2015; 21(40): 11246-11259 doi: 10.3748/wjg.v21.i40.11246
|
| 19 |
Amy McMillan, Adebola E. Orimadegun, Mark W. Sumarah, Justin Renaud, Magdalena Muc da Encarnacao, Gregory B. Gloor, Olusegun O. Akinyinka, Gregor Reid, Stephen J. Allen. Metabolic derangements identified through untargeted metabolomics in a cross-sectional study of Nigerian children with severe acute malnutrition. Metabolomics 2017; 13(2) doi: 10.1007/s11306-016-1150-2
|
| 20 |
Nicholas-Paul Delicata, Neville Azzopardi, Pierre Ellul. Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”. Canadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/3238925
|
| 21 |
Bruce E. Sands, Shashidhar Joshi, Jonathan Haddad, Johannes M. Freudenberg, Deepa Elizabeth Oommen, Ethan Hoffmann, Stewart W. McCallum, Eric Jacobson. Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis. Inflammatory Bowel Diseases 2016; 22(3): 607 doi: 10.1097/MIB.0000000000000597
|
| 22 |
Grazyna Piotrowicz, Agnieszka Klufczyńska, Jacek Kowerzanow, Piotr Banaszkiewicz,, Grażyna Rydzewska. Crohn’s disease activity evaluation based on imaging studies and biomarkers. Gastroenterology & Hepatology: Open Access 2018; 9(2) doi: 10.15406/ghoa.2018.09.00292
|
| 23 |
Tsvetelina Veselinova Velikova, Zoya Angelova Spassova, Lyuben Mitkov Milatchkov, Dobriana Georgieva Panova, Ekaterina Ivanova Ivanova - Todorova, Kalina Dinkova Tumangelova - Yuzeir, Ekaterina Krasimirova Kurteva, Dobroslav Stanimirov Kyurkchiev, Siragan Arshavir Deredjan, Rosen Kirilov Nikolov, Iskra Petrova Altankova, Lyudmila Mateva Vladimirova. Dynamics of Some Routine Immunological Parameters During Anti - TNF Therapy in Patients with Crohn’s Disease. Annals of Colorectal Research 2018; 6(1) doi: 10.5812/acr.68674
|
| 24 |
Natalia Pedersen, Dorit Vedel Ankersen, Maria Felding, Henrik Wachmann, Zsuzsanna Végh, Line Molzen, Johan Burisch, Jens Rikardt Andersen, Pia Munkholm. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World Journal of Gastroenterology 2017; 23(18): 3356-3366 doi: 10.3748/wjg.v23.i18.3356
|
| 25 |
Toshiki G. Nakashige, Emily M. Zygiel, Catherine L. Drennan, Elizabeth M. Nolan. Nickel Sequestration by the Host-Defense Protein Human Calprotectin. Journal of the American Chemical Society 2017; 139(26): 8828 doi: 10.1021/jacs.7b01212
|
| 26 |
M. Iborra, B. Beltrán, A. Fernández‐Clotet, A. Gutiérrez, B. Antolín, J.M. Huguet, R. De Francisco, O. Merino, D. Carpio, S. García‐López, F. Mesonero, P. Navarro, R. Ferreiro‐Iglesias, A.Y. Carbajo, M. Rivero, J.P. Gisbert, M.C. Piñero‐Pérez, D. Monfort, L. Bujanda, M.F. García‐Sepulcre, A. Martín‐Cardona, F. Cañete, C. Taxonera, E. Domènech, P. Nos. Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry. Alimentary Pharmacology & Therapeutics 2019; 50(3): 278 doi: 10.1111/apt.15371
|
| 27 |
Anna Luisa Bathe, Eirini Mavropoulou, Nicolae-Catalin Mechie, Golo Petzold, Volker Ellenrieder, Steffen Kunsch, Ahmad Amanzada, Bruno Bonaz. Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn’s disease and ulcerative colitis. PLOS ONE 2019; 14(10): e0223893 doi: 10.1371/journal.pone.0223893
|
| 28 |
Cristiana Bonifacio, Giovanni Savini, Christian Reca, Federico Garoli, Riccardo Levi, Giulia Vatteroni, Luca Balzarini, Mariangela Allocca, Federica Furfaro, Arianna Dal Buono, Alessandro Armuzzi, Silvio Danese, Michela Matteoli, Maria Rescigno, Gionata Fiorino, Letterio S. Politi. The gut-brain axis: Correlation of choroid plexus volume and permeability with inflammatory biomarkers in Crohn's disease. Neurobiology of Disease 2024; 192: 106416 doi: 10.1016/j.nbd.2024.106416
|
| 29 |
Ik Hyun Jo, Chang-Nyol Paik, Ji Min Lee, Do Seon Song, Yeon-Ji Kim. Effect of Trimebutine and Rifaximin on Breath Hydrogen and Methane by Glucose Breath Test in Patients With Functional Bloating: A Randomized Double-blind Clinical Trial. Journal of Neurogastroenterology and Motility 2024; 30(2): 220 doi: 10.5056/jnm23029
|
| 30 |
Agata Ladić, Silvija Čuković-Čavka. Gastrointestinal Complications of Diabetes. Clinical Gastroenterology 2018; : 125 doi: 10.1007/978-3-319-75856-5_10
|
| 31 |
Yuko Okuyama, Yosuke Doi, Naoto Matsuyama, Michiyo Uchino, Takayuki Yamamoto. A novel sol particle immunoassay for fecal calprotectin in inflammatory bowel disease patients. Clinica Chimica Acta 2016; 456: 1 doi: 10.1016/j.cca.2016.02.012
|
| 32 |
Simon Haarder, Per W. Kania, Thomas Lindebo Holm, Maki Ohtani, Kurt Buchmann. Comparison of Two Chemically-Induced Colitis-Models in Adult Zebrafish, Using Optical Projection Tomography and Novel Transcriptional Markers. Open Journal of Immunology 2016; 6(04): 154 doi: 10.4236/oji.2016.64016
|
| 33 |
Jun Lee. Fecal Calprotectin in Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 2016; 67(5): 233 doi: 10.4166/kjg.2016.67.5.233
|
| 34 |
Hany A. Hussein, Rasha S. Mohamed. Fecal B-cell-activating factor as a new noninvasive marker in the evaluation of ulcerative colitis Egyptian patients: a comparative cross-sectional study. The Egyptian Journal of Internal Medicine 2019; 31(4): 563 doi: 10.4103/ejim.ejim_118_19
|
| 35 |
Quentin Delefortrie, Patricia Schatt, Alexandre Grimmelprez, Patrick Gohy, Didier Deltour, Geneviève Collard, Patrick Vankerkhoven. Comparison of the Liaison® Calprotectin kit with a well established point of care test (Quantum Blue — Bühlmann-Alere®) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up. Clinical Biochemistry 2016; 49(3): 268 doi: 10.1016/j.clinbiochem.2015.10.010
|
| 36 |
Liron Caplan, Kristine A. Kuhn. Gastrointestinal and Hepatic Disease in Spondyloarthritis. Rheumatic Disease Clinics of North America 2018; 44(1): 153 doi: 10.1016/j.rdc.2017.09.004
|
| 37 |
Xu Teng, Yuming Yang, Lu Liu, Lijuan Yang, Jie Wu, Mei Sun, Lingfen Xu. Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide. Pediatric Research 2020; 88(5): 792 doi: 10.1038/s41390-020-0812-y
|
| 38 |
Anil Kumar Asthana, Antony B Friedman, Giovanni Maconi, Christian Maaser, Torsten Kucharzik, Mamoru Watanabe, Peter R Gibson. The failure of gastroenterologists to apply intestinal ultrasound in inflammatory bowel disease in the Asia‐Pacific: A need for action. Journal of Gastroenterology and Hepatology 2015; 30(3): 446 doi: 10.1111/jgh.12871
|
| 39 |
Rikke Asmussen Andreasen, Lars Erik Kristensen, Torkell Ellingsen, Robin Christensen, Xenofon Baraliakos, Jimmi Wied, Claus Aalykke, Thomas Ulstrup, Berit Schiøttz-Christensen, Hans Christian Horn, Amir Emamifar, Bent Duerlund, Lars Fischer, Inger Marie Jensen Hansen. Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study. BMJ Open 2017; 7(7): e015536 doi: 10.1136/bmjopen-2016-015536
|
| 40 |
Ji Min Lee, Kang‐Moon Lee, Yoon Yung Chung, Yang Woon Lee, Dae Bum Kim, Hea Jung Sung, Woo Chul Chung, Chang‐Nyol Paik. Clinical significance of the glucose breath test in patients with inflammatory bowel disease. Journal of Gastroenterology and Hepatology 2015; 30(6): 990 doi: 10.1111/jgh.12908
|
| 41 |
Shapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch, Waliul Islam Khan. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. Journal of Gastroenterology 2016; 51(5): 434 doi: 10.1007/s00535-016-1182-4
|
| 42 |
Serdar Özdemir. Inflammation: Complexity and significance of cellular and molecular responses. Journal of Acute Disease 2024; 13(1): 3 doi: 10.4103/jad.jad_129_23
|
| 43 |
Athanasios Kostas, Spyros I Siakavellas, Charalambos Kosmidis, Anna Takou, Joanna Nikou, Georgios Maropoulos, John Vlachogiannakos, George V Papatheodoridis, Ioannis Papaconstantinou, Giorgos Bamias. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World Journal of Gastroenterology 2017; 23(41): 7387-7396 doi: 10.3748/wjg.v23.i41.7387
|
| 44 |
Miriam Wiestler, Fabian Kockelmann, Momme Kück, Arno Kerling, Uwe Tegtbur, Michael P. Manns, Masoumeh Attaran-Bandarabadi, Oliver Bachmann. Quality of Life Is Associated With Wearable-Based Physical Activity in Patients With Inflammatory Bowel Disease: A Prospective, Observational Study. Clinical and Translational Gastroenterology 2019; 10(11): e00094 doi: 10.14309/ctg.0000000000000094
|
| 45 |
Sylvie Buffet-Bataillon, Clémence Landreau, Laurent Siproudhis, Vincent Cattoir, Guillaume Bouguen. Bacterial gut dysbiosis is associated with Crohn’s disease symptoms but not with elevated fecal calprotectin. Clinics and Research in Hepatology and Gastroenterology 2021; 45(2): 101669 doi: 10.1016/j.clinre.2021.101669
|
| 46 |
Yang Woon Lee, Kang-Moon Lee, Ji Min Lee, Yoon Yung Chung, Dae Bum Kim, Yeon Ji Kim, Woo Chul Chung, Chang-Nyol Paik. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity. The Korean Journal of Internal Medicine 2019; 34(1): 72 doi: 10.3904/kjim.2016.324
|
| 47 |
Saranya Kittanakom, Md. Sharif Shajib, Kristine Garvie, Joceline Turner, Dan Brooks, Sufian Odeh, Robert Issenman, V. Tony Chetty, Joseph Macri, Waliul I. Khan. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/1450970
|
| 48 |
Yoshihiro Tatsumi, Kazuki Kakimoto, Azusa Hara, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Ryoji Koshiba, Yuki Hirata, Kazuhiro Ota, Takako Miyazaki, Shiro Nakamura, Kayoko Sakagami, Shoko Arimitsu, Hiroaki Ito, Hiroki Nishikawa. Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis. Journal of Clinical Medicine 2023; 12(22): 7165 doi: 10.3390/jcm12227165
|
| 49 |
Juan María Vázquez Morón, Héctor Pallarés Manrique, Francisco H. Machancoses , Manuel Ramos Lora , Carlos Ruíz Frutos . Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohns disease with fecal calprotectin. Revista Española de Enfermedades Digestivas 2017; 109 doi: 10.17235/reed.2017.4542/2016
|
| 50 |
Sihem Ait‐Oudhia, Yi Ting (Kayla) Lien, Sumit Basu, Lawrence Lesko, Stephan Schmidt. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases. 2019; : 209 doi: 10.1002/9781119289234.ch10
|